BMI View: Government initiatives to reduce the reliance on pharmaceutical imports pose challenges for
multinational drugmakers. The weak ruble has seen prices of foreign medicines rise to unaffordable levels
and has led to state intervention in the form of domestic bi ..."
BMI View: Belarus poses challenges for multinational drugmakers given government initiatives to reduce
the reliance on medicinal imports. The weak ruble has seen prices of foreign medicines rise to unaffordable
levels and has led to state intervention in the form of d ..."
BMI View: Government initiatives to boost the nascent domestic pharmaceutical industry and reduce the
reliance on imports will limit the attractiveness of Belarus to multinational drugmakers. Government
interference, in the form of domestic bias in the medicine tender ..."
BMI View: Belarus continues to present limited opportunities for drugmakers owing to the heightened
economic risk in the country. Regional security risks, namely between Russia and the west, poor
governance and heavy state presence in the economy will present consider ..."
BMI View: Collapsing external trade will have a highly damaging impact on living standards in Belarus,
impacting incomes, employment and consumer sentiment, and we expect the pharmaceutical sector to be
hurt by these factors. We expect the Belarusian government to inc ..."
BMI View: The volatility of the Belarusian rouble and high inflation will hurt consumer incomes and
therefore the growth outlook of the pharmaceutical market over the next two years. Furthermore, increased
scrutiny by President Lukashenko over pharmaceutical imports i ..."
BMI View: The Belarusian market will suffer from the impact of depreciation and economic instability as
the country's economy becomes ever more reliant on Russian loans to function. Furthermore, wage growth
mandated by the government will become unsustainable, threate ..."
BMI View: The Belarusian market will suffer from the impact of prolonged rouble depreciation and
economic instability. Further compounding risk to the market are tensions in neighbouring Ukraine and
Russia and absolute erosion of consumer purchasing power. Geopolitica ..."
BMI View: The Belarusian economy is set to suffer a prolonged period of economic instability as a result of
a decline in global potash prices and an escalating trade war with Russia. If Russo-Belarusian relations
cannot be patched up, state revenues are set to decline ..."
BMI View: Pharmaceutical sales in Belarus are poised to recover as the fallout from the breaking of the
potash joint venture Uralkai-Belaruskali subsides, and the risk of currency devaluation temporarily relents.
However, Belarus must now contend with the consequences ..."